• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

ABR_Website_Image.jpg

— December 4, 2017

Valneva to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference

Read more

— Stock information

@valnevase




















-
— July 26, 2017
Valneva and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus

Read more
— Financial Calendar

February 15, 2018
Preliminary 2017 Results (Revenues, Cash)

March 22, 2018
2017 Financial Statements

May 17, 2018
Q1 2018 Interim Results

See all dates






JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



J.P. Morgan 36th Annual Healthcare Conference 2018
San Francisco, US
January 08-11, 2018


 
Please update your browser...